'It was like a godsend' — GLP-1 drugs show promise against hormonal disorder that causes constant weight gain and forces women to shave facial hair

Fortune · 38

GLP-1 drugs tested in a study for polyendocrine metabolic ovarian syndrome improved symptoms for participants including Charlotte Touzalin, who saw slower facial hair growth and normalized periods after semaglutide shots. In the June Fertility and Sterility report, 8 of 11 participants who completed the trial lost at least 10% of their body weight, with a median loss of about 42 pounds and a median testosterone drop of 52%. More research is underway and doctors are increasingly prescribing GLP-1s off label, but insurance coverage barriers can leave patients unable to continue treatment.